Products
products
Regulatory Intelligence
Understand and act on global regulatory change.
Inspection Intelligence
Anticipate inspection focus and enforcement risk.
Site Intelligence
Evaluate site and supplier risk.
Postmarket Intelligence
Detect product quality & safety signals.
platform & data
Redica App
Instant insights on the platform.
Integrated solutions
End-to-end connected intelligence.
API
Real-time, scalable data access.
Our Data
Globally-trusted quality data & insights.
Explore integrations
Solutions
by function
CMO/CDMO
Quality Teams
Regulatory Compliance
Supply Chain
Regulatory Affairs
Digital IT Teams
by industry
Pharmaceutical
MedTech
Cosmetics
Supplements & OTC
Food
Financial Services
featured case study
How a Top 10 Pharma Company Transformed CMO and API Oversight
latest report
Mapping Predictable Patterns Driving Complete Response Letters
Resources
resources by type
Assessments
Insights on inspections, risk, and compliance.
Blog
Evaluate readiness and compliance maturity.
Reports
Benchmark industry trends and best practices.
Webinars
Hear from industry leaders and Redica experts.
latest report
Mapping Predictable Patterns Driving Complete Response Letters
Quick links
Document Store
Knowledge Center
Login
Contact us
Company
Login
book a demo
Login
book a demo
Redica Systems
Enforcement
FDA Issues 38-Page 483 to Solid Oral Dosage Manufacturer
February 23, 2021
Conference Spotlight
FDA Chooses Not to Perform Virtual Inspections in Contrast with Non-U.S. Agencies
February 18, 2021
(Video) A 21st Century Solution for Regulated Industries
February 16, 2021
Conference Spotlight
Impact of the EU MDR on Combination Product Sale and Registration in the EU
February 11, 2021
Surveying the Smart Combination Product Ecosystem
February 9, 2021
An Analysis of 2015 to 2019 FDA 483 Data
January 28, 2021
What is Enforcement Analytics?
January 26, 2021
Conference Spotlight
EU Animal Health Legislation Aims to Reduce Industry Burden
January 21, 2021
Conference Spotlight
Russian Inspectorate Weighs in on Remote Audits and International Harmonization
January 20, 2021
Conference Spotlight
FDA Combination Products Policy and Guidance Changes
January 14, 2021
Enforcement
OTC Skincare Firm Receives Warning Letter Due to CGMP Concerns
January 13, 2021
New Year, New Enforcement Analytics
January 7, 2021
Conference Spotlight
FDA OMQ Regulatory Actions Increase Dramatically in FY2020
January 5, 2021
Our Top 5 Webinars of 2020
December 30, 2020
Our Top 5 Articles of 2020
December 29, 2020
Overcoming CMC Complexity for Cell & Gene Products
December 24, 2020
Ashley Boam on FDA’s Proposed Quality Maturity Model
December 22, 2020
Redica Announces Addition of Jason Kerr
December 21, 2020
Previous
load more
12 / 24